Price
Target price
€25.40
€25.40
-1.550%
-0.4
-1.550%
€27.08
12.12.25 / Tradegate
WKN: 883035 / Symbol: TEVA / Name: Teva Pharma / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Teva Pharmaceutical Industries Ltd ADR Stock
We can see a decrease in the price for Teva Pharmaceutical Industries Ltd ADR. Compared to yesterday it has lost -€0.400 (-1.550%).
With 17 Buy predictions and not the single Sell prediction the community is currently very high on Teva Pharmaceutical Industries Ltd ADR.
With a target price of 27 € there is a slightly positive potential of 6.3% for Teva Pharmaceutical Industries Ltd ADR compared to the current price of 25.4 €.
Our community identified positive and negative aspects for Teva Pharmaceutical Industries Ltd ADR stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Teva Pharmaceutical Industries Ltd ADR stock. On the other hand our users think that "Conscious of the environment" could be a problem in the future.
Pros and Cons of Teva Pharmaceutical Industries Ltd ADR in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Teva Pharmaceutical Industries Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | -1.550% | 3.673% | 13.901% | 57.764% | 18.140% | 208.252% | 198.122% |
| Bayer AG ADR | 1.700% | 4.678% | 30.657% | 90.426% | 80.444% | -31.154% | -23.504% |
| Roche Holding AG ADR | -1.300% | 2.864% | 9.153% | 25.461% | 27.949% | 10.827% | 19.456% |
| Astrazeneca ADR | -0.650% | -0.645% | 1.316% | 20.313% | 20.313% | 17.021% | 71.875% |
Comments
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Bank of America Corporation from $29.00 to $32.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $35.00 price target on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $28.00 to $31.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
